< Back to all clusters
[HEALTH] · United States

ACTG Opens Hormone Therapy Study for Women Living With HIV in Menopause Transition

CHAPEL HILL, N.C., April 21, 2026 (GLOBE NEWSWIRE) — ACTG, a global clinical trials network focused on HIV and other infectious diseases, announced the opening of the HoT study (Menopausal Hormone Therapy for Women Living with HIV, also known as A5424).